Evidence map›Paper›PMID 31721415›Full record

ArticleEMBO reports2020

Arpin is critical for phagocytosis in macrophages and is targeted by human rhinovirus.

Jamil Jubrail, Kshanti Africano-Gomez, Floriane Herit, Anna Mularski, Pierre Bourdoncle, Lisa Oberg, Elisabeth Israelsson, Pierre-Regis Burgel, Gaell Mayer, Danen M Cunoosamy and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in EMBO reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Phagocytosis at a glance.Journal of cell science · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Jamil JubrailUniversité de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR 8104, Paris, France.
Kshanti Africano-GomezUniversité de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR 8104, Paris, France.
Floriane HeritUniversité de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR 8104, Paris, France.
Anna MularskiUniversité de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR 8104, Paris, France.
Pierre BourdoncleUniversité de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR 8104, Paris, France.
Lisa ObergTranslational Science and Experimental Medicine, Research and Early Development, Respiratory Inflammation and Autoimmunity, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Elisabeth IsraelssonTranslational Science and Experimental Medicine, Research and Early Development, Respiratory Inflammation and Autoimmunity, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Pierre-Regis BurgelUniversité de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR 8104, Paris, France.
Gaell MayerLate-stage development, Respiratory, Inflammation and Autoimmunity (RIA), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Danen M CunoosamyTranslational Science and Experimental Medicine, Research and Early Development, Respiratory Inflammation and Autoimmunity, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Nisha KurianRespiratory Inflammation and Autoimmune Precision Medicine Unit, Precision Medicine, Oncology R&D, AstraZeneca, Gothenburg, Sweden.
Florence NiedergangUniversité de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR 8104, Paris, France.ORCID 0000-0002-7064-830X
Centre National de la Recherche Scientifique · FRAstraZeneca (Sweden) · SE

Funding

ANR 16-CE13-0007-01AstraZeneca
6 · The paper itself

Abstract

Human rhinovirus is a causative agent of severe exacerbations of chronic obstructive pulmonary disease (COPD). COPD is characterised by an increased number of alveolar macrophages with diminished phagocytic functions, but how rhinovirus infection affects macrophage function is still unknown. Here, we describe that human rhinovirus 16 impairs bacterial uptake and receptor-mediated phagocytosis in macrophages. The stalled phagocytic cups contain accumulated F-actin. Interestingly, we find that human rhinovirus 16 downregulates the expression of Arpin, a negative regulator of the Arp2/3 complex. Importantly, re-expression of the protein rescues defective internalisation in human rhinovirus 16-treated cells, demonstrating that Arpin is a key factor targeted to impair phagocytosis. We further show that Arpin is required for efficient uptake of multiple targets, for F-actin cup formation and for successful phagosome completion in macrophages. Interestingly, Arpin is recruited to sites of membrane extension and phagosome closure. Thus, we identify Arpin as a central actin regulator during phagocytosis that it is targeted by human rhinovirus 16, allowing the virus to perturb bacterial internalisation and phagocytosis in macrophages.

Indexed as

PhagocytosisRhinovirusCarrier ProteinsHumansMacrophagesMacrophages, AlveolarPhagosomesarpin protein, humanCarrier ProteinsactinArp2/3bacteriaMacrophagephagosome

Identifiers

PMID31721415
PMCPMC6945061
OpenAlexW2988257990

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.